2/18
12:22 pm
alny
Alnylam Pharmaceuticals (NASDAQ:ALNY) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $510.00 price target on the stock.
Low
Report
Alnylam Pharmaceuticals (NASDAQ:ALNY) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $510.00 price target on the stock.
2/17
09:26 am
alny
Rating for ALNY
Medium
Report
Rating for ALNY
2/13
07:59 am
alny
Rating for ALNY
Low
Report
Rating for ALNY
2/12
02:08 pm
alny
Alnylam Pharmaceuticals (NASDAQ:ALNY) had its "buy" rating reaffirmed by analysts at Bank of America Corporation.
Low
Report
Alnylam Pharmaceuticals (NASDAQ:ALNY) had its "buy" rating reaffirmed by analysts at Bank of America Corporation.
2/12
01:52 pm
alny
Rating for ALNY
Low
Report
Rating for ALNY
2/12
01:52 pm
alny
Rating for ALNY
Low
Report
Rating for ALNY
1/30
11:49 am
alny
Rating for ALNY
Low
Report
Rating for ALNY
1/30
11:49 am
alny
Rating for ALNY
Low
Report
Rating for ALNY
1/28
08:10 am
alny
Rating for ALNY
Low
Report
Rating for ALNY
1/28
08:10 am
alny
Rating for ALNY
Low
Report
Rating for ALNY
1/28
08:03 am
alny
Alnylam Pharmaceuticals (NASDAQ:ALNY) is now covered by analysts at Barclays PLC. They set an "overweight" rating and a $527.00 price target on the stock.
Low
Report
Alnylam Pharmaceuticals (NASDAQ:ALNY) is now covered by analysts at Barclays PLC. They set an "overweight" rating and a $527.00 price target on the stock.
1/20
10:59 am
alny
Rating for ALNY
Low
Report
Rating for ALNY
1/20
10:59 am
alny
Rating for ALNY
Low
Report
Rating for ALNY
1/20
10:44 am
alny
Rating for ALNY
Low
Report
Rating for ALNY
1/20
10:44 am
alny
Rating for ALNY
Low
Report
Rating for ALNY
1/12
07:17 am
alny
Alnylam Pharmaceuticals (NASDAQ:ALNY) had its "outperform" rating reaffirmed by analysts at Raymond James Financial, Inc..
Low
Report
Alnylam Pharmaceuticals (NASDAQ:ALNY) had its "outperform" rating reaffirmed by analysts at Raymond James Financial, Inc..
1/12
06:10 am
alny
Rating for ALNY
Medium
Report
Rating for ALNY
1/12
06:10 am
alny
Rating for ALNY
Medium
Report
Rating for ALNY
1/7
10:57 am
alny
Alnylam Pharmaceuticals (NASDAQ:ALNY) is now covered by analysts at Oppenheimer Holdings, Inc.. They set an "outperform" rating and a $500.00 price target on the stock.
Low
Report
Alnylam Pharmaceuticals (NASDAQ:ALNY) is now covered by analysts at Oppenheimer Holdings, Inc.. They set an "outperform" rating and a $500.00 price target on the stock.
12/15
03:39 pm
alny
Rating for ALNY
Low
Report
Rating for ALNY
12/11
08:15 am
alny
Rating for ALNY
Low
Report
Rating for ALNY